With shares of Caribou Biosciences (NASDAQ: CRBU) up by 51% in the past 30 days, there's more than one reason why you might want to consider a purchase for yourself. Between its recent release of some ...
Looking for a good show to attend this week? We've got a number of excellent artists in this week's Can't Miss Concerts, from April 9 to 15, from a number of genres, so whether you've got a craving ...
Caribou's cell therapy programs are among the most advanced that exist. So far, they also appear to be relatively safe and quite effective. The company has more than enough money to reach its next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback